OMERS Administration Corp’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122K Sell
67,900
-56,500
-45% -$120K ﹤0.01% 987
2025
Q4
$279K Buy
+124,400
New +$327K ﹤0.01% 829
2021
Q4
Sell
-40,000
Closed -$392K 421
2021
Q3
$392K Buy
+40,000
New +$394K 0.01% 191

Other funds holding PROK

OMERS Administration Corp's PROK Position: Q1 2026 in Review

OMERS Administration Corp reduced its ProKidney (PROK) stake by 45% in Q1 2026, selling an estimated $120K and leaving 67,900 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #987.

OMERS Administration Corp first reported a position in PROK in Q3 2021 and has held it in 3 quarters since. The position peaked at $392K in Q3 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • OMERS Administration Corp held 67,900 shares of ProKidney worth $122K as of Q1 2026.
  • OMERS Administration Corp sold 56,500 ProKidney shares in Q1 2026, an estimated $120K.
  • ProKidney made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #987 holding.
  • OMERS Administration Corp first reported a position in ProKidney in Q3 2021 and has held it in 3 quarters since.
  • OMERS Administration Corp's ProKidney position peaked at $392K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.